Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Michael DiStefano

Concepts (129)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Negotiating
5
2025
34
2.610
Why?
Morals
4
2024
84
2.350
Why?
Medicare
6
2025
907
2.310
Why?
Technology Assessment, Biomedical
7
2026
44
1.890
Why?
Cost-Benefit Analysis
8
2025
632
1.680
Why?
Direct-to-Consumer Advertising
2
2024
8
1.600
Why?
Medicare Part D
3
2023
23
1.560
Why?
Drug Costs
6
2026
115
1.440
Why?
Alzheimer Disease
3
2024
640
1.410
Why?
Health Priorities
4
2026
45
1.310
Why?
Prescription Drugs
2
2023
110
1.270
Why?
Drug Industry
2
2026
46
0.970
Why?
Health Facility Closure
1
2025
8
0.910
Why?
Drug Compounding
1
2026
106
0.910
Why?
Anti-Obesity Agents
1
2026
67
0.900
Why?
Pharmacies
1
2025
40
0.880
Why?
Community Pharmacy Services
1
2025
46
0.880
Why?
Glucagon-Like Peptides
1
2026
76
0.840
Why?
Health Care Rationing
1
2024
53
0.840
Why?
Bioethics
2
2024
26
0.830
Why?
Comparative Effectiveness Research
2
2025
170
0.800
Why?
Social Values
2
2023
40
0.790
Why?
United States
20
2026
16041
0.770
Why?
Pregnancy in Diabetics
1
2024
123
0.740
Why?
Medicare Part C
1
2023
38
0.730
Why?
Public Opinion
1
2022
61
0.690
Why?
Pharmaceutical Preparations
1
2023
172
0.660
Why?
Health Equity
1
2023
139
0.630
Why?
Hypoglycemic Agents
2
2026
1411
0.600
Why?
Qualitative Research
2
2025
1720
0.600
Why?
Blood Glucose Self-Monitoring
1
2024
704
0.570
Why?
Social Justice
1
2019
82
0.550
Why?
Humans
38
2026
145625
0.490
Why?
Social Media
1
2019
158
0.480
Why?
Wearable Electronic Devices
1
2017
75
0.460
Why?
South Africa
4
2023
262
0.430
Why?
Blood Glucose
1
2024
2357
0.410
Why?
Health Services Needs and Demand
2
2026
283
0.410
Why?
Public Health
1
2018
573
0.380
Why?
Policy
2
2024
147
0.350
Why?
Diabetes Mellitus, Type 2
1
2026
2623
0.350
Why?
Aged
11
2026
26251
0.340
Why?
Cross-Sectional Studies
5
2026
5875
0.330
Why?
Economics, Pharmaceutical
2
2019
10
0.300
Why?
Biosimilar Pharmaceuticals
2
2026
28
0.280
Why?
Decision Making
3
2026
987
0.280
Why?
Depression
1
2018
1566
0.270
Why?
Diabetes Mellitus, Type 1
1
2024
3930
0.260
Why?
Antibodies, Monoclonal, Humanized
2
2025
992
0.260
Why?
Surveys and Questionnaires
3
2026
6050
0.250
Why?
Oklahoma
1
2026
21
0.240
Why?
Ethical Analysis
1
2026
6
0.240
Why?
Pharmacy Technicians
1
2025
1
0.230
Why?
Cost Sharing
1
2026
23
0.230
Why?
Costs and Cost Analysis
2
2023
216
0.230
Why?
Genetic Therapy
2
2025
303
0.230
Why?
Utah
1
2025
82
0.220
Why?
Health Services Accessibility
2
2025
1101
0.220
Why?
Biomedical Technology
2
2022
49
0.220
Why?
Focus Groups
2
2025
587
0.220
Why?
Cost Savings
1
2024
85
0.210
Why?
Reimbursement Mechanisms
1
2025
78
0.210
Why?
Germany
1
2024
139
0.200
Why?
Quality-Adjusted Life Years
1
2024
119
0.200
Why?
Medicaid
2
2025
472
0.200
Why?
Medicare Part B
1
2023
7
0.200
Why?
Technology
1
2024
100
0.190
Why?
Adult
6
2026
40821
0.190
Why?
National Health Programs
1
2023
23
0.190
Why?
Hemophilia B
1
2023
65
0.190
Why?
Antineoplastic Agents, Immunological
1
2025
200
0.190
Why?
Psychotherapy
1
2024
179
0.190
Why?
Female
10
2026
79080
0.180
Why?
Pharmacists
1
2025
260
0.180
Why?
Human Rights
1
2022
19
0.180
Why?
Mental Competency
1
2022
28
0.180
Why?
Male
10
2026
73014
0.170
Why?
Hemophilia A
1
2023
149
0.170
Why?
Drug Approval
1
2022
93
0.170
Why?
Health Expenditures
1
2023
196
0.170
Why?
Intensive Care Units, Neonatal
1
2024
295
0.170
Why?
United States Food and Drug Administration
1
2022
207
0.160
Why?
Middle Aged
5
2026
36359
0.160
Why?
Pressure Ulcer
1
2021
41
0.160
Why?
Anemia, Sickle Cell
1
2025
322
0.160
Why?
Informed Consent
1
2022
194
0.160
Why?
Pneumonia, Ventilator-Associated
1
2021
58
0.160
Why?
Patient Positioning
1
2021
70
0.160
Why?
Patient Participation
1
2024
454
0.150
Why?
Economic Competition
1
2019
13
0.150
Why?
Legislation, Drug
1
2019
72
0.140
Why?
Public Health Surveillance
1
2019
84
0.140
Why?
Civil Disorders
1
2018
8
0.140
Why?
Colorado
2
2025
4588
0.140
Why?
Cell Phone
1
2019
83
0.130
Why?
Chronic Disease
2
2026
1824
0.130
Why?
Delivery of Health Care
1
2024
942
0.130
Why?
Research Design
1
2024
1139
0.130
Why?
Caregivers
1
2026
1079
0.130
Why?
Retrospective Studies
3
2024
17291
0.130
Why?
Diabetes Mellitus
1
2026
1101
0.120
Why?
Developing Countries
1
2019
312
0.120
Why?
Stress Disorders, Post-Traumatic
1
2024
889
0.120
Why?
Carcinoma, Non-Small-Cell Lung
1
2025
1194
0.120
Why?
Reproducibility of Results
1
2024
3396
0.110
Why?
Violence
1
2018
275
0.110
Why?
Infant, Newborn
1
2024
6449
0.090
Why?
Cohort Studies
1
2023
6045
0.090
Why?
Lung Neoplasms
1
2025
2674
0.090
Why?
Pregnancy
1
2024
7217
0.090
Why?
Young Adult
2
2026
14240
0.080
Why?
Adolescent
2
2026
22451
0.070
Why?
Drugs, Generic
1
2026
28
0.060
Why?
Stakeholder Participation
1
2026
90
0.060
Why?
Serotonin and Noradrenaline Reuptake Inhibitors
1
2024
6
0.050
Why?
Markov Chains
1
2025
128
0.050
Why?
Models, Economic
1
2025
63
0.050
Why?
Needs Assessment
1
2026
403
0.050
Why?
Health Policy
1
2026
399
0.050
Why?
Artificial Intelligence
1
2026
385
0.040
Why?
Ontario
1
2019
91
0.040
Why?
Japan
1
2019
149
0.040
Why?
Public Policy
1
2019
79
0.040
Why?
Hospitals
1
2021
730
0.030
Why?
Critical Care
1
2021
700
0.030
Why?
Aged, 80 and over
1
2025
8351
0.020
Why?
Treatment Outcome
1
2024
11744
0.020
Why?
Risk Factors
1
2019
10840
0.010
Why?
Child
1
2022
22638
0.010
Why?
DiStefano's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)